Bioactive Compounds
-
BA2307 BurfiralimabSummary: Burfiralimab (hzVSF-v13) is a monoclonal antibody directed against waveform proteins expressed on the surface of virus-infected cells with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. - BA2306 SARS-CoV-2-IN-1Summary: SARS-CoV-2-IN-1 is a potent inhibitor.
- BA2305 CnicinSummary: Cnicin is a sesquiterpene lactone.
- BA2304 XP-59Summary: XP-59 is an effective inhibitor.
- BA2303 RdRP-IN-2Summary: RdRP-IN-2 is an RNA-dependent inhibitor of RNA polymerase.
- BA2302 KW-8232Summary: KW-8232 is an orally active anti-osteoporotic agent.
- BA2301 SSAA09E1Summary: SSAA09E1 is a histone L blocker (5.33 μM).
- BA2300 SHEN26Summary: SHEN26 (ATY014) is a potent, orally active inhibitor.
- BA2299 SSAA09E3Summary: SSAA09E3 is an entry inhibitor.
- BA2298 SARS-CoV-2-IN-14Summary: SARS-CoV-2-IN-14 is a potent inhibitor.